CRSP SG&A Expense Growth
Crispr Therapeutics Ag · SG&A Expense Growth
CRSP SG&A Expense Growth
Latest reported0.77%period ending
CRSP FY SG&A Growth (YoY) (0.00% → 0.77%)
Latest values, visible window
High-resolution chart · PNG
CRSP sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 0.7742% | |
| -4.1819% | |
| -25.6695% | |
| 2.7826% | |
| 16.2606% | |
| 35.0602% | |
| 31.4615% | |
| 34.7301% | |
| 15.4205% | |
| 131.7093% | |
| 162.0845% | |
| 0% |